pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·40m ago·1 min read
save

Bristol Myers to merge R&D under Massacesi, research head to exit

Nov 12, 2026·read at Endpoints ↗

Bristol Myers Squibb is changing up its R&D leadership, moving out head of research Robert Plenge and giving his responsibilities to Cristian Massacesi, the company's chief medical officer and head of development work. The shakeup ...

source

Reporting by Endpoints.

read at Endpoints ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoBlackstone commits up to $1.5B for R&D of Pfizer's ex-Metsera GLP-1Endpoints
  • 16h agoNeurosterix pulls in $105M for schizophrenia drug, taps Cobenfy vetsEndpoints
  • 16h agoHow Hims plans to reinvigorate its businessEndpoints
  • 21h agoFlagship merges two startups; J&J scores a bipolar mania successEndpoints
  • 23h agoBeeline reveals Phase 2 lupus data from old Bristol Myers drugEndpoints